$338 Million is the total value of Sands Capital Ventures, LLC's 23 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 9.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NU HLDGS LTD | $66,355,973 | -8.1% | 9,152,548 | 0.0% | 19.63% | -8.1% | ||
| PATH | UIPATH INCcl a | $52,468,996 | +3.3% | 3,066,569 | 0.0% | 15.52% | +3.3% | |
| DASH | DOORDASH INCcl a | $47,961,099 | +4.0% | 603,512 | 0.0% | 14.19% | +4.0% | |
| SNOW | Buy | SNOWFLAKE INCcl a | $32,967,613 | -13.2% | 215,799 | +0.0% | 9.75% | -13.1% |
| New | RAYZEBIO, INC. | $26,542,076 | – | 1,195,589 | +100.0% | 7.85% | – | |
| Sell | SAMSARA INC | $23,564,720 | -44.9% | 934,737 | -39.4% | 6.97% | -44.9% | |
| TXG | 10X GENOMICS INC | $19,873,013 | -26.1% | 481,770 | 0.0% | 5.88% | -26.1% | |
| New | KLAVIYO, INC. | $16,195,370 | – | 469,431 | +100.0% | 4.79% | – | |
| ACRIVON THERAPEUTICS INC | $15,798,904 | -26.2% | 1,652,605 | 0.0% | 4.67% | -26.2% | ||
| ABOS | ACUMEN PHARMACEUTICALS INC | $14,180,861 | -13.7% | 3,417,075 | 0.0% | 4.20% | -13.7% | |
| OLK | OLINK HLDG ABsponsored ads | $10,406,332 | -21.3% | 705,514 | 0.0% | 3.08% | -21.3% | |
| TARS | TARSUS PHARMACEUTICALS INC | $4,620,200 | -1.7% | 260,000 | 0.0% | 1.37% | -1.7% | |
| TSHA | TAYSHA GENE THERAPIES INC | $2,290,599 | +378.8% | 724,873 | 0.0% | 0.68% | +377.5% | |
| SPRB | SPRUCE BIOSCIENCES INC | $1,778,636 | +5.1% | 787,007 | 0.0% | 0.53% | +5.2% | |
| MASS | 908 DEVICES INC | $1,580,138 | -2.9% | 237,258 | 0.0% | 0.47% | -2.9% | |
| CANDEL THERAPEUTICS INC | $746,798 | -27.0% | 811,737 | 0.0% | 0.22% | -27.1% | ||
| CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $144,784 | +32.5% | 865 | +16.3% | 0.04% | +34.4% |
| CPNG | COUPANG INCcl a | $143,446 | -2.3% | 8,438 | 0.0% | 0.04% | -2.3% | |
| Buy | TOAST INCcl a | $133,376 | -6.0% | 7,121 | +13.3% | 0.04% | -7.1% | |
| DDOG | DATADOG INC | $124,429 | -7.4% | 1,366 | 0.0% | 0.04% | -7.5% | |
| ABSCI CORPORATION | $76,301 | -13.2% | 57,804 | 0.0% | 0.02% | -11.5% | ||
| CFLT | Sell | CONFLUENT INC | $34,377 | -28.1% | 1,161 | -14.3% | 0.01% | -28.6% |
| GITLAB INC | $29,755 | -11.5% | 658 | 0.0% | 0.01% | -10.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UIPATH INC | 9 | Q3 2023 | 30.2% |
| DOORDASH INC | 9 | Q3 2023 | 19.6% |
| SNOWFLAKE INC | 9 | Q3 2023 | 14.4% |
| ACUMEN PHARMACEUTICALS, INC | 9 | Q3 2023 | 10.0% |
| 908 DEVICES INC | 9 | Q3 2023 | 1.8% |
| TARSUS PHARMACEUTICALS INC | 9 | Q3 2023 | 1.4% |
| TAYSHA GENE THERAPIES INC | 9 | Q3 2023 | 2.0% |
| CANDEL THERAPEUTICS, INC | 9 | Q3 2023 | 1.3% |
| SPRUCE BIOSCIENCES INC | 9 | Q3 2023 | 0.7% |
| ABSCI CORPORATION | 9 | Q3 2023 | 0.1% |
View Sands Capital Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-15 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-09 |
View Sands Capital Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.